Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Adds Phase II Oncology Candidate Via Acquisition Of Aton

Mar 01 2004

• By The Pink Sheet

Related Content

Merck Adds To Phase III Pipeline With Lundbeck Sleep-Aid Gaboxadol

Feb 16 2004

Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals

Dec 15 2003

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window